PDA/FDA Glass Packaging Conference 2013
May 15 - 16, 2013
Bethesda MD , USA
Register for the 2013 PDA/FDA Glass Packaging Conference and the 2013 PDA/FDA Container Closure Components and Systems Workshop and receive $200 off your attendance.
Pharmaceutical manufacturers, regulators, and glass suppliers all share a common goal of assuring the highest quality products (including packaging) for patients. The 2013 PDA/FDA Glass Packaging Conference will provide information on integration of proteins with surfaces, an update on delamination issues and discuss key information trends. This meeting will also further discuss best practices to preventing and/or detecting at risk glass packaging and review current expectations to ensure that recalls are avoided and container closure integrity is assured.
Learning Objectives
At the completion of this program, participants will be able to:
• Discuss current issues with glass packaging
• Identify best practices on glass handling
• Summarize current expectations for incoming glass and pharmaceutical product packaging
• Describe effective glass supplier relationship for product improvement
• Identify new analytical techniques that are being used to analyze bioproduct interactions with solid surfaces
• Describe the historical basis for the interaction of biomolecules with packaging surfaces
• Identify technologies that are available for glass strengthening
• Describe how the manufacturing environment can create glass defects that lead to eventual breakage
• Examine possible improvements in glass manufacturing, characterization, handling or packaging to be pursued
Who Should Attend
Persons involved in selection and quality assurance of glass packaging; manufacturing of products packaged in glass; glass suppliers; and regulators.
Specifically, pharmaceutical and biopharmaceutical professionals with the following responsibilities are encouraged to participate: Quality Assurance | Packaging | S
Pharmaceutical manufacturers, regulators, and glass suppliers all share a common goal of assuring the highest quality products (including packaging) for patients. The 2013 PDA/FDA Glass Packaging Conference will provide information on integration of proteins with surfaces, an update on delamination issues and discuss key information trends. This meeting will also further discuss best practices to preventing and/or detecting at risk glass packaging and review current expectations to ensure that recalls are avoided and container closure integrity is assured.
Learning Objectives
At the completion of this program, participants will be able to:
• Discuss current issues with glass packaging
• Identify best practices on glass handling
• Summarize current expectations for incoming glass and pharmaceutical product packaging
• Describe effective glass supplier relationship for product improvement
• Identify new analytical techniques that are being used to analyze bioproduct interactions with solid surfaces
• Describe the historical basis for the interaction of biomolecules with packaging surfaces
• Identify technologies that are available for glass strengthening
• Describe how the manufacturing environment can create glass defects that lead to eventual breakage
• Examine possible improvements in glass manufacturing, characterization, handling or packaging to be pursued
Who Should Attend
Persons involved in selection and quality assurance of glass packaging; manufacturing of products packaged in glass; glass suppliers; and regulators.
Specifically, pharmaceutical and biopharmaceutical professionals with the following responsibilities are encouraged to participate: Quality Assurance | Packaging | S
Related events
PDA/FDA Glass Packaging Conference May 15 - 16, 2013
